PDFファイル - 医薬品医療機器総合機構
Contents
1. 15 25 C 2 8 PPD 1 2 3 4 HIV HBV HCV2. pikk PDTA WES 2 8 8 CES x EF 20 2
3. 1 000ppm 1 2 1 121 20 0 1 BETTE CR URBES 1 2 8 2 m3 4 m 14 R mE
4. PTH 2 ALP PTH 3 L 4 H 5 PPD 4 4 3 1 2 3 2 PTH BUR EG 1 EHER TE RERO CLEIA C H 1 PTH PTH ALP PTH TIM 1 2 3 2 PPD ALP
5. 2 15 25 2 8 2 8 2 8 C 30 3 L 2 0mL H s 4 PPD 20 HTF 15280
6. 21700AMY00124000 LKPP1 Wis l 2 P TH 3 4 5 6 1
7. 400pg mL Opg mL 10 20 5 C V 15 3 2 500pg mL 3pg mL 000pg mL C V 5 5 6 3 10 C V 7 9 8 6 CLK pg mL 94 111 1 19 PTH 900 3 600 7 200pg mL 90 101 CLEIA 5 y n 62 r 0 998 y 1 01 x 0 20 8 2 3 MEERE EL EBA AIRE AME CLEIA y n 55 r 0 995 y 1 03x 11 35 2000
8. PTH LPHIZ 1 E 2 K PTH 29 2 293pg mL 89 7 96 0 TUR 3 pg mL 200mg dL 2014 4 4 2013 4 3 513mg dL Lie 513mg dL PTH 29 2 293 500 1 000 2 000 3 000mg dL PTH 102 107 101 112 89 108 45 69 a O PTH COLES CHELA N 1 34 ER S BLUR EN AMLO A amp iii
9. y 5 1 000 n 140 r 0 997 y 1 08x 145pg mL 2000 156pg mL 1 21 1 1 2 3 1 2 3 4 5 6 7 1 2 3 4 Sf HIV 1 2 HBs HCV HIV HBV HCV 0 1
10. L H 4 2 Low High Ts m 1 2 pg mL 88 95 11 67pg mL 30pg mL E 9596988pH 16 87pg mL 38pg mL 194 10 69pg mL 31pg mL E
11. SI 101 8517 1 3 4 TI EL 03 5994 2516 1 11 1 SI 101 8517 TH13 4 10381399M1_03 PILKPP 16 2008 05 15
12. 1 2 3 4 5 6 bb HE 1 2 3 4 500 20 PTH 22 81 TUR 1 PTH PTI BCT PTH PTH PT PTH MES 9 9 AMP 1 12 9 PTH
13. D 0pg mL 400pg mL
14. 1 2 3 4 5 6 E 7 i 8 9 10 11 PTH 3 EDTA 7 10 JL CRI ERIC dO TR EDTA 4 4 3 PPD PTH Logue FUR PRICE 1 50zL 100uL 150 u LO mE XIMENA ET EDTA 280 L AED TIERE EDTA
15. PTH PTH PTH 48 3 C y pg mL 1 34 300 ND 1 44 100 000 ND 44 68 100 000 ND 53 84 100 000 ND 10 000 ND ND N PTH PTH C 44 84 Er ER 1 PTH 7 84 2 o 1000 BR 1 1
16. LKPP1 100 1 6 100 7 5mL X 1 1 L 2 0mL x 4 3 H 2 0mL x 4 3 LSUBX PPD 105mL X 2 1 Brux 1 Logue FC Fraser WD O Reilly DStJ Beastall GH The circadian 2 3 rhythm of intact parathyroid hormone 1 84 and nephrogenous cyclic adenosine monophosphate in normal men J Endocrinol 1989 121 R1 R3 UK National External Quality Assurance Scheme NEQAS for PTH ACTH and Calcitonin Distribution 65 2001 Bowers GN Brassard C Sena SF Measurement of ionized calcium in serum with ion selective electrodes Clin Chem 1986 32 1437 47 4 5 6 7 8 9 10 11 12 13 v Halvorsen JF Gautvik VT Gautvik KM Improved diagnosis of primary hyperparathyroidism by defining the inverse relationship between serum immunoreactive parathyroid hormone and calcium Scand J Clin Lab Invest 1986 46 435 42 Hawker CD Clark SW Martin KJ Slatopolsky E Di Bella FP Radioimmunoassay of parathyroid hormone clinical utility and interpretation In Thompson NW Vinik Al editors Endocrine Surgery Update New York Grune amp Statton 1983 321 40 Boyd JC Ladenson JH Value of laboratory tests in the differential diagnosis of hypercalcemia Am J Med 1984 77 863 72 Groth TL Ljunghall S De Verdier C H Optimal screening for patients with hy
17. 15 28C 30 5 PTH LPHZ 6 1000 37 60 2 8 30 20 6 LPWS2 50 50 u LM PPD 200 u L 37 10 12 L PTH 4 5 1 2 3 1 2 3 LH
18. perparathyroidism with use of serum calcium observation a decisiont theoretical analysis Scand J Clin Lab Invest 1983 43 699 707 Kleeman K Kleeman CR Parathyroid hormone and calcitonin Contemp Endocrinol 1985 2 247 344 Orwoll ES Meier D Alterations in calcium vitamin D and parathyroid hormone physiology in normal men with aging relationship to the development of senile osteopenia J Clin Endocrinol Metab 1986 63 1262 9 Kao PC Parathyroid hormone assay Mayo Clin Proc 1982 57 596 7 Heath H Tests of parathyoid function utility and limitations American Association for Clinical Chemistry Continuing Education in Endocrinology and Metabolism Endo Feb 1984 2 8 10 pages Johnson DR Howarth AT Differential diagnosis of hypercalcemia CRC Crit Rev Clin Lab Sci 1984 21 51 97 Audran M Kumar R The physiology and pathophysiology of vitamin D Mayo Clin Proc 1985 60 851 66 a gt 14 Boscato LM Stuart MC Heterophilic antibodies a problem for all immunoassays Clin Chem 1988 34 27 33 15 16 HAERES 17 22 3 251 253 1997 PRISE du intact PTH 46 10 925 930 1998 lt
Download Pdf Manuals
Related Search